Progress in chemoprevention of breast cancer

This publication has 33 references indexed in Scilit:

• The Italian Breast Cancer Prevention Trial with Tamoxifen
  Annals of the New York Academy of Sciences, 2006
• Overview of the main outcomes in breast-cancer prevention trials
  The Lancet, 2003
• Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial
  The Lancet, 2002
• Assessing the Risk of Breast Cancer
  New England Journal of Medicine, 2000
• Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial
  The Lancet, 1998
• Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial among hysterectomised women
  The Lancet, 1998
• The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study
  Annals of Oncology, 1996
• Retinoids and Apoptosis: Implications for Cancer Chemoprevention and Therapy
  JNCI Journal of the National Cancer Institute, 1995
• Adjuvant Tamoxifen Therapy for Early Stage Breast Cancer and Second Primary Malignancies
  JNCI Journal of the National Cancer Institute, 1995
• Distribution of fenretinide in the mammary gland of breast cancer patients
  European Journal of Cancer and Clinical Oncology, 1991